2021 annual financial data

Bionano Genomics 2021 Operating margin

Direct answer

Operating margin was -428.79%.

Operating income was -77.1M USD and net income was -72.44M USD.
Operating cash flow was -71.93M USD.

Get free Bionano Genomics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
17.98M USD
Operating income
-77.1M USD
Net income
-72.44M USD
Operating cash flow
-71.93M USD